Laddar...
Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer
Acquisition of resistance to gemcitabine is a challenging clinical and biological hallmark property of refractory pancreatic cancer. Here, we investigated whether glycogen synthase kinase (GSK)‐3β, an emerging therapeutic target in various cancer types, is mechanistically involved in acquired resist...
Sparad:
| I publikationen: | Cancer Sci |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734171/ https://ncbi.nlm.nih.gov/pubmed/32986894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14668 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|